Aarti Pharmalabs Ltd (AARTIPHARM) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 543748 | NSE: AARTIPHARM | Pharmaceuticals & Drugs | Small Cap

Aarti Pharmalabs Share Price

722.05 -0.95 -0.13%
as on 05-Dec'25 16:59

Aarti Pharmalabs Ltd (AARTIPHARM) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 543748 | NSE: AARTIPHARM | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Aarti Pharmalabs

Based on:

Overall Rating
Bole Toh

1. Quality

2. Valuation

Overvalued

3. Price Trend

Aarti Pharmalabs stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
26.77
Market Cap:
6,545.2 Cr.
52-wk low:
550.3
52-wk high:
971.5

Is Aarti Pharmalabs Ltd an attractive stock to invest in?

1. Is Aarti Pharmalabs Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Aarti Pharmalabs Ltd is a average quality company.

2. Is Aarti Pharmalabs Ltd undervalued or overvalued?

The key valuation ratios of Aarti Pharmalabs Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Aarti Pharmalabs Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Aarti Pharmalabs Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Aarti Pharmalabs:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Aarti Pharmalabs Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 0%0%0%0%-8.1%-1.9%18%15.6%16.6%17.6%-
Value Creation
Index
NANANANA-1.6-1.10.30.10.20.3-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 0000009411,5111,5021,7711,793
Sales YoY Gr.-NANANANANANA60.6%-0.6%17.9%-
Adj EPS 0000-0.8-0.24,268.21922.128.227
YoY Gr.-NANANANANANA-99.6%16.6%27.5%-
BVPS (₹) 00009.39.149,558.5158.7178.9203.3210
Adj Net
Profit
0000-0-0107172200255244
Cash Flow from Ops. 0000-00-64.8216184340-
Debt/CF from Ops. 000000-511.41.2-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANA23.5%17.9%
Adj EPS NANA-81.2%27.5%
BVPSNA85.5%-84%13.6%
Share Price - - - 14.1%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
0000-8.1-216.612.613.114.713.1
Op. Profit
Mgn %
00000019.120.42324.123.8
Net Profit
Mgn %
00000011.311.413.314.413.6
Debt to
Equity
000000.10.30.10.20.20.1
Working Cap
Days
000000163219256245122
Cash Conv.
Cycle
00000011615016615053

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 23.47%

Sales growth is good in last 4 quarters at 14.98%

Return on Equity has declined versus last 3 years average to 13.10%

Net Profit has been subdued in last 3 years -81.24%

Latest Financials - Aarti Pharmalabs Ltd.

Standalone Consolidated
TTM EPS (₹) 27 26.5
TTM Sales (₹ Cr.) 1,793 1,906
BVPS (₹.) 210 225.7
Reserves (₹ Cr.) 1,858 2,001
P/BV 3.44 3.20
PE 26.77 27.30
From the Market
52 Week Low / High (₹) 550.25 / 971.50
All Time Low / High (₹) 269.00 / 971.50
Market Cap (₹ Cr.) 6,545
Equity (₹ Cr.) 45.3
Face Value (₹) 5
Industry PE 40.6

Management X-Ray of Aarti Pharmalabs:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.010.01
* Pledged shares as % of Promoter's holding (%)

Valuation of Aarti Pharmalabs - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Aarti Pharmalabs

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales009411,5111,5021,771
Operating Expenses 007611,2031,1561,345
Manufacturing Costs00202170181213
Material Costs00452818752879
Employee Cost 0080114120140
Other Costs 0027101103112
Operating Profit -0-0180308346427
Operating Profit Margin (%) --19.1%20.4%23.0%24.1%
Other Income 00311114
Interest 0011201726
Depreciation 0037566679
Exceptional Items 000000
Profit Before Tax -0-0134233275336
Tax 0027627479
Profit After Tax -0-0107172201257
PAT Margin (%) --11.3%11.4%13.4%14.5%
Adjusted EPS (₹)-0.8-0.24,269.119.022.128.4
Dividend Payout Ratio (%)0%0%0%11%14%18%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 001,2391,4391,6211,842
Share Capital 000454545
Reserves -0-01,2391,3931,5761,797
Minority Interest000000
Debt00325207251395
Long Term Debt00000104
Short Term Debt00325207251291
Trade Payables00132212255249
Others Liabilities 00132119170238
Total Liabilities 001,8271,9762,2972,724

Fixed Assets

Gross Block001,1011,3041,4721,653
Accumulated Depreciation00400455519594
Net Fixed Assets 007018489531,059
CWIP 00187102137369
Investments 0040556257
Inventories00444538582544
Trade Receivables00304372449553
Cash Equivalents 0056044
Others Assets 009361110138
Total Assets 001,8271,9762,2972,724

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity -00-65216184340
PBT -0-0134233275336
Adjustment 00467781109
Changes in Working Capital 00-230-38-125-47
Tax Paid 00-15-57-47-59
Cash Flow From Investing Activity 00-134-116-184-420
Capex 00-136-99-189-433
Net Investments 000-18-52
Others 00211012
Cash Flow From Financing Activity 00255-157479
Net Proceeds from Shares 000000
Net Proceeds from Borrowing 00000100
Interest Paid 00-11-20-17-23
Dividend Paid 000-18-18-32
Others 00266-1183934
Net Cash Flow 0056-564-1

Finance Ratio

PARTICULARSMar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)N/AN/A17.2312.8313.1114.86
ROCE (%)N/AN/A18.0315.616.5517.61
Asset Turnover Ratio001.030.790.70.71
PAT to CFO Conversion(x)N/AN/A-0.611.260.921.32
Working Capital Days
Receivable Days0011882100103
Inventory Days00172119136116
Payable Days005377113105

Aarti Pharmalabs Ltd Stock News

Aarti Pharmalabs Ltd FAQs

The current trading price of Aarti Pharmalabs on 05-Dec-2025 16:59 is ₹722.0.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Aarti Pharmalabs stood at ₹6,545.2.
The latest P/E ratio of Aarti Pharmalabs as of 04-Dec-2025 is 26.77.
The latest P/B ratio of Aarti Pharmalabs as of 04-Dec-2025 is 3.44.
The 52-week high of Aarti Pharmalabs is ₹971.5 and the 52-week low is ₹550.2.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Aarti Pharmalabs is ₹1,793 ( Cr.) .

About Aarti Pharmalabs Ltd

Aarti Pharmalabs Limited (APL) (Formerly known as Aarti Organics Limited) is a leading Indian manufacturer of Pharmaceuticals and Nutraceuticals with a global footprint.

Over the past two decades, enabled by cutting-edge R&D and manufacturing capabilities APL has evolved as a reliable partner of choice for generic players and innovators across the globe. The company specialises in generic APIs, generic intermediates, and xanthine derivatives. It delivers CDMO services for drug substance/NCE development and manufacturing for innovative pharmaceutical and biotech firms with a focus on the Ph-I/II/III, launch, and commercial phases. It has dedicated facilities for the production of HPAPIs, corticosteroids, cytotoxic medicines, and oncology products.

With the biggest manufacturing capacity in India for its flagship product ‘Caffeine’ APL has emerged as a preferred partner for the Beverages, Nutraceuticals manufacturing companies, and Pharmaceuticals Industries across the world.

Business area of the company

The company is an, internationally recognised manufacturer of Active Pharmaceutical Ingredients (API), pharmaceutical intermediates, New Chemical Entities (NCE), and xanthine derivatives situated in India. In order to build a sustainable future, it integrates process chemistry proficiency (recipe focus) with scale-up engineering proficiency (asset utilisation).

Products and services

  • API
  • Intermediates
  • CDMO Services
  • Caffeine
  • Xanthine Derivatives
  • Acid & Allied

You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×